Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.0088 | 0.8 |
mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.0086 | 0.8 |
mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |